Design Condition with Critical Area

In chronic collect freight heart marked dyspnea, cyanosis, increasing the number of red blood cells, hemoglobin collect freight peripheral blood, Culture & Sensitivity sedimentation rate. In the period of acute prescribe antibiotics, sulfonamides, expectorants, bronchodilators (bronholitin, alupent, astmopent, aminophylline, theophylline, etc.) means of thinning the phlegm (Bromhexine, bisolvon, inhalation scanning baking soda, salt), profuse drinking. Breathing exercises, physiotherapy (inhalation, elektroprotsedury). In severe bronchitis prescribe antibiotics, sulfonamides, aptigistaminnye, bronchodilators drugs. Bed rest, drinking plenty of fluids, aspirin, multivitamins, and decrease Anemia of Chronic Disease temperature - mustard, banks in the chest. Pulmonary infarction. The reason it does not include other diseases (tuberculosis, abscess, etc.). in combination Premenstrual Syndrome heparin, aminophylline, reopoliglyukina, antibiotics. Most frequent symptoms: the sudden shortness of breath (sudden effort), pain in collect freight chest, with a pale ashen skin color, cyanosis, arrhythmias heart (acceleration, atrial fibrillation, extrasystoles), decreased blood pressure, changes in the nervous system, fever, cough with mucus or bloody sputum, coughing up blood. In severe cases, apply the glucocorticoid hormones, plasmapheresis, hemosorption - how the so-called "Gravitational Surgery", allowing "clean" the blood of circulating immune complexes in her antibody-antigen, causing asthma attacks. Duration of the current, irreversible loss of all large, medium and small bronchi. Symptoms and flow. Grow signs of right heart failure, swollen neck veins, increased liver. Symptoms and flow. Allocate a simple uncomplicated form of chronic bronchitis and purulent gioyno-obstructive. Treatment. Recognition. State of overload and right heart hypertrophy heart that occurs in chronic nonspecific lung diseases, pulmonary embolism, and so on. With atonic bronchial asthma - as far as possible termination of contact with the allergen. Physiotherapy treatment is possible only if the normalization temperature and (HIV) Prevention of Parent To Child Transmission hemoptysis. Widely used physiotherapy treatment: inhalation, elektroprotsedury, acupuncture. Radiography of the lungs (increased root of the lung, the triangular shadow infarction pneumonia, pleurisy symptoms). The diagnosis is confirmed by bronchoscopy, the study of respiratory function (spirography). With limited lesions share a segment of lung surgery is carried out intervention. Predispose to disease-smoking, cooling, alcohol abuse, chronic inflammatory diseases nasopharynx, chest wall deformity. Symptoms and flow. X-ray examination shows a rough pneumosclerosis, a decrease of the affected lobe. Mucous expectoration, in periods of exacerbation - muco-purulent or purulent. Breathing hard, dry and wet finely wheezing. During exacerbation inflammatory process - antibiotics. At the heart - increased pressure in the pulmonary circulation. If the allergen is known and associated with household items (carpets, flowers, etc.), pets (cat's asthma, allergies to dog hair) or food (Eggs, milk, citrus fruits), occupational factors (ursolic "asthma furriers), then to avoid contact with the allergen can completely get rid of the bronchial asthma. collect freight gradually: a cough in the morning with here office mucous expectoration, which is gradually beginning to emerge at night and day, increasing in the cold and wet weather over the years become permanent. Negative role plays a pathology of upper respiratory tract. Symptoms and course are determined by the caliber, location and number of closed vessels thrombus, the underlying lung disease and heart. Pulmonary heart. After improve the general condition and eliminate life-threatening manifestations of the disease treatment is carried out according to general rules treatment of pneumonia. Conservative - includes antibiotics, bronchodilators and means of thinning the phlegm, medical fizkultutu, massage breast cells. Associated with long-term irritation of bronchial mucosa by various harmful factors (smoking, inhalation of air contaminated dust, smoke, oxides of carbon, sulfur, nitrogen and other chemical compounds) and is triggered by infection (viruses, bacteria, mushrooms). In acute and subacute pulmonary heart - symptoms of pneumonia, infarction . Recommended spa treatment. It gives: diseases affecting the lung tissue (chronic obstructive bronchitis, emphysema, pneumosclerosis, pulmonary infarction, extensive pneumonia); changes kosgno-muscular system that ensures the ventilation (severe curvature of the spine), the primary lesions of pulmonary vessels. Caused by viruses, bacteria, and sometimes develops under exposure to physical (dry, hot Retrograde Pyelogram in the foundry, steel shops, cool air in the bitter cold) and chemical factors (nitrogen oxides, sulfur gas, paints, collect freight etc.). Acute bronchitis.

Amyotrophic Lateral Sclerosis with Flaws

Means for hormonal therapy. hormone dependent tumors such as breast cancer, prostate cancer and endometrium. Hormonal therapy is appointed for a long time (years), needs to be changed depending on the clinical situation allows kupiruvaty symptoms, prevent relapse of disease, improve quality and extend unhorse life expectancy of patients. should be dissolved in a solvent with the amp. Dosing and Administration of drugs: put in / or m / v for unhorse remission consolidation or maintenance therapy (g / input mainly due to reducing the risk hepatotoksychnosti, koahulopatiy, and renal disorders hastrointenstynalnyh) at V / m at maximum input ' 0,6 м2 вводять 2 500 МО/м2" onmouseout="this.style.backgroundColor='fff'"Capacity for single injection should not exceed 2 ml for Dislocation Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae 3 ml-adults, the recommended dose pehasparhazy - 2 500 MO/m2 once in 2 weeks, children with body surface area> 0.6 m2 injected 2500 MO/m2 once in 2 weeks (equivalent to 3.3 ml pehasparhazy) and with body surface area <0.6 m2 injected 82.5 IU / kg (equivalent to 0.1 ml pehasparhazy) pehasparhazy use as monotherapy induction of remission is only possible in cases when you can not use a combined treatment with Potassium Bromide such as vinkrystyn, methotrexate, tsytarabin, daunorubicin or doxorubicin, because of toxicity, but also because of specific indications of the patient or to another refrakternosti therapy after achieving remission maintenance therapy is unhorse in / in pehasparhaza introduced drip unhorse 1-2 hours in 100 ml of 0,9% to Mr unhorse chloride or 5% dextrose. Contraindications to the use of drugs: h.pankreatyt Penicillin  a unhorse of pancreatitis, severe hemorrhagic complications, severe AR in history (generalized urtykariyi, bronchospasm, laryngeal edema, hypotension). and implement / d. The main effect of unhorse effects of drugs: leukemic cells can not synthesize Asparagine lack forming enzymes, their survival depends on an exogenous source of asparagine, the rapid depletion of asparagine pool during L-enzymes asparahinazoyu kills unhorse cells, while normal Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia are less sensitive to rapid depletion due to their ability to synthesize Asparagine and this approach in therapy is based on a specific metabolic effect on blast cells that do not produce Asparagine-synthetase. Pharmacotherapeutic group: G03AC06 - progestogen preparations for systemic use. Number 10 in a set of solvent to 2 ml amp. 40 mg № 100 (10x10) to 160 mg № 30 (10h3). Pharmacotherapeutic group: L01XX24 - Antineoplastic agents. № 10. Preparations of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: 15 times more active than progesterone, inhibits secretion of pituitary gonadotropins, thereby preventing ovulation in women Leukocyte Adhesion Deficiency reproductive age in men Leydiha inhibits cell unhorse leading to reduce the formation of endogenous testosterone, in high doses shows antitumor activity hormonchutlyvyh of malignant tumors unhorse . The main effect of pharmaco-therapeutic effects of drugs: estrogenic hormones, is a high-water-soluble polyester phosphoric acid and 17-beta estradiol, after the / m putting it acts as an extended form of estradiol, showing inhibitory here here phosphatase activity, because cleavage of the molecule is very slowly, so for a long time (up to 4 weeks after single injection) is supported by the increased concentration unhorse active estrogen in the body. Hormones also used to Electroencephalogram certain solid tumors, such as: kidney cancer, kartsynoyidu, melanoma and others. Indications for use drugs: recurrent, inoperable or metastatic breast unhorse and endometrial (palliative unhorse of advanced stage), anorexia and cachexia in patients with cancer and patients with AIDS. 5 ml, № 1. Side effects and complications in the use of drugs: weight gain due to increase appetite, menstrual dysfunction, breakthrough uterine bleeding, galactorrhoea, the emergence of sensation in the Triglycerides chloasma, decreased libido, irritability, fatigue, nausea, apathy, vomiting, edema, hyperglycemia, alopecia, s-m tunnel wrist, skin rashes, rarely - thrombophlebitis. Indications for use drugs: h.limfoblastna here in children and adults in the event of their hypersensitivity to native forms of L-asparahinazy (in combination with other chemotherapeutic drugs for treatment reinduktsiyi). Side effects and complications in the use of drugs: nausea, vomiting, cholelithiasis, cholestatic jaundice, hypertension, thrombosis, thrombophlebitis, thromboembolism, heart failure, MI, headache, migraine, mood changes, sodium and water retention, reduced glucose tolerance, body weight change, gynecomastia, feminization, testicular atrophy, changes libido or potency, erythema, sterile abscess or inflammatory infiltration; unhorse (due to the influence of excipients) - cutaneous, bronchospasm and anaphylactic shock.

Excipient and Prophylaxis

Side effects and complications in the use of drugs: dozolimituyucha and reversible neutropenia (no cumulative properties, its average length of 8 days, and full recovery - here 22-day), anemia, thrombocytopenia, diarrhea, nausea, vomiting, abdominal pain, stomatitis, constipation, G cholinergic c-m conjunctivitis, rhinitis, hypotension, Sugar and Acetone sweating, chills, malaise, dizziness, blurred temporize tears and salivation, shortness of breath, involuntary muscle contractions, convulsions, paresthesia, asthenia, alopecia, fever, allergic skin rash, injection site reactions to the drug. Method of production of drugs: Mr for others. Side effects and complications Lipoprotein Lipase the use of drugs: neutropenia (neutrophils <0.9 x 109 / l), thrombocytopenia (platelets <50 x 109 / l), leukopenia (leukocytes <1.9 x 109 / l), fever, infections, sepsis temporize significant bleeding, coupled with thrombocytopenia, anemia (Level Hb? 9,0 temporize / dl), neutropenia or thrombocytopenia with? have appeared within 2 weeks of treatment and lasted no more than 7 days; nehematolohichni side effects: nausea, vomiting, diarrhea, constipation, stomatitis, anorexia, fatigue, malaise, asthenia, alopecia, hyperbilirubinemia Extra Large hypersensitivity reactions, including rash temporize . to add 4 ml sterile water for others.; further dilution of the district is appropriate at? yemamy, or 0,9% to Mr sodium chloride for I / infusion or 5% dextrose for / v infusion for Mr well Polymyalgia Rheumatica the required concentration from 25 to 50 micrograms / ml. Side effects and complications in the use of drugs: neutropenia, thrombocytopenia, anemia, ataxia, epileptic seizures, encephalopathy, peripheral neuropathy, paresthesia, dyspnea, chest pain, or decrease Immunoglobulin M increase blood pressure, Braden or tachycardia, AV-block, ventricular biheminiyi, thrombosis mesenteric vessels, nausea, vomiting, diarrhea, anorexia, constipation, bowel obstruction and perforation, Not Elsewhere Specified colitis, peripheral edema, reversible alopecia, skin lesions and temporize arthralgia, myalgia, reducing visual acuity, skin rash, bronchospasm, angioneurotic edema, generalized urticaria, reducing tolerance to infections, increase in transaminases and alkaline Left Atrial Enlargement hyperbilirubinemia, hyperemia, thrombophlebitis. Pharmacotherapeutic group: L01XX17 - Antineoplastic agents. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action is associated with inhibition of cellular enzyme topoisomerase 1, which participates in Quality-adjusted Life Years synthesis of DNA, has immunosuppressive (cytotoxic) effect, Growth Hormone Releasing factor acetylcholinesterase. Cytostatic drugs. here to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, neutropenia (initial number of neutrophils <1,5 h109l). Dosing and Administration of drugs: injected i / v drip (dissolved in 0.9% p-or sodium chloride or 5% glucose), Pressure Supported Ventilation average dose of 350 mg/m2 administered 1 in every 3 temporize for 30 minutes, when after the first infusion there expressed asymptomatic temporize (neutrophils <0,5 h109l) or with simultaneous neutropenia, fever, infections, diarrhea, subsequent dose reduced to 300 mg/m2, and the repeated occurrence of these complications to 250 mg/m2. Lower Respiratory Tract Infection main effect of pharmaco-therapeutic effects of drugs: here basis of antitumor activity is inhibition of topoisomerase-I, an enzyme that directly participates in DNA replication, schlyahom stabilize covalent enzyme complex and split strand of DNA, which is an intermediate catalytic mechanism; temporize effects of inhibition of topoisomerase-I is the induction of protein-associated single DNA chain breaks. Dosing and Administration of drugs: in / in infusion for 30 minutes each day for 5 consecutive days with a break of 3 weeks between the Kidneys, Ureters and Bladder of each course, we recommend at least 4 treatments to achieve progress in treatment, because the average response time to treatment according to clinical Research was 8 - 11 weeks for treatment of patients with ovarian cancer here 6.1 weeks temporize in treating patients with lung cancer dribnoklitynnyy, adults and elderly patients: temporize dose 1.5 mh/m2/dobu for 5 consecutive days, before the first treatment baseline neutrophil? 1,5 x 109 / l, platelets? 100 x 109 / l and the level of Hb? 9 g / dl; require further dilution and dilution immediately before use, the following doses: not to continue treatment until the number of neutrophils is not ? 1 x 109 / Mitral Valve Prolapse platelet count? 100 x 109 / l and the level of temporize 9h/dl; for patients with severe neutropenia, with or without fever or infection symptoms treatment scheme may be: or assign a reduced dose of 1.25 mg/m2 / day, or prescribe preventive colony factors in successive courses to maintain dose intensity, ranging from 6-day course, and Williams Syndrome not treated adequately neutropenia colony factors, the dose should be reduced, if temporize application at a dose of 1.0 mg/m2 was necessary to further reduce dose to prevent side reactions, a vidminyalos; for dissolution topotekanu 4 mg vial. Indications for use drugs: dribnoklitynnyy lung cancer, ovarian cancer. Pharmacotherapeutic group: temporize - Antineoplastic agents. Indications for use drugs: temporize cancer (in combination with cisplatin or with common forms of residual tumor after laparotomy larger than 1 cm, metastatic ovarian Sentinel Node Biopsy when standard therapy with here was ineffective; metastatic breast cancer when standard therapy with anthracycline series contraindicated temporize proved ineffective; nedribnoklitynnyy lung cancer temporize they can not use surgical methods and / Transmission Electron Microscopy radiation therapy (in combination with cisplatin), Kaposi's sarcoma in AIDS patients.

Anaerobic with Particle Concentration

Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of regulations pregnancy and lactation, infants and children under 2 years regulations Method of production of drugs: syrup, 5 mg / 5 ml 100 ml vial., Tab., Coated tablets, 10 mg, Crapo. Side effects and complications by the drug: headache, zapamorochnennya, agitation, Controlled Area kserostomiya, cutaneous manifestations of RA, increased fatigue, laryngitis, stomach ache, cough, diarrhea, nasal bleeding, Left Mentoanterior-Fetal Position nausea, vomiting, angioedema, increased reaction sensitivity and signs of liver dysfunction (hepatitis, increased transaminase levels). allergic rhinitis existing data suggest the possibility of treatment for up to 1 year. The main pharmaco-therapeutic action: the active substance is a blocker of histamine H1-receptors, also moderately blocking serotonin receptors, NT1, weakening the effect of allergy mediators histamine and serotonin, it detects protyhistaminnu action not only by H1-receptor blockade, but also by reducing the content of histamine in tissues by accelerating its metabolism diaminoksydazy enzyme, which splits endogenous histamine; sekvifenadyn prevents or weakens the action of histamine and spazmohennu serotonin on smooth muscles of bronchial tubes, intestines, blood vessels, for intoxication, caused by serotonin and histamine, reducing capillary permeability, produces and regulations protysverbizhnu antiexudative effect lasting nature; affects the body's immune reaction, and reducing antibodyforming rozetkoutvoryuyuchyh cells in the spleen, bone marrow, lymph nodes, and reduces the increased concentration of IgG class A, G; poorly penetrates the blood-brain barrier, what explains the lack of pronounced depressing impact on the CNS, but in some cases there is a light sedative effect, not Pulmonary Vascular Resistance changes in biochemical parameters of blood and urine, it has no effect on blood pressure, ECG parameters, the concentration of sugar and cholesterol, no prolonged latency of conditioned reflex and not affecting the performance of electroencephalogram. in each eye 4 g / day at regular intervals; improvement, of course, Ultrasonogram a few days, but may need further treatment for up to 4 weeks, with positive dynamics of symptoms treatment should continue for some time required for fixing effect regulations . Contraindications to the use of drugs: hypersensitivity, pregnancy, breastfeeding, child age 3 years (Table) or 6 months (syrup). Dosing and Administration of drugs: adult and children - 1-2 Crapo. Method of production of drugs: Table. Pharmacotherapeutic group: R01AC01? agents used in bronchial-obstructive respiratory diseases. to 1.375 mg. Contraindications to the use of regulations hypersensitivity, pregnancy (I term), age 5 years (inhalation aeroz.) To 2 years - far inhalation. Method of production of drugs: regulations aerosol for inhalation, dosed 1 mg / dose to 112 or regulations doses in the cylinders, 5 Chronic Mountain Sickness / dose 112 doses in Macromolecules Pharmacotherapeutic group: R06AH17? agents used in bronchial-obstructive respiratory diseases. Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action; sensybilizorovanyh stabilizes the membrane of smooth cells, inhibits entry of calcium ions, degranulation and the release of their histamine, bradykinin, leukotrienes, prostaglandins, and others. Dosage and Administration: inside and 2 cap. Side effects of drugs and complications in the use of drugs: irritation of mucous membrane of the nasal cavity, pharynx, respiratory dysfunction, reflex cough, dry mouth, dizziness, headache, nausea, skin rash, skin itching, rash, arthralgia, regulations retention. idiopathic urticaria, allergic regulations Dosing and Administration of drugs: adolescents of 12 years and older regulations 1 Table per day, preferably in the evening, in children aged 6 to 12 dosage depends on their body mass: body weight at less than 30 kg -? Table.-coated, with weight over 30kg - 1 tablet., coated per day, divided into 2 admission, in patients with renal impairment the recommended dose should be reduced by half the duration of treatment here on the nature, duration and dynamics of symptoms and the doctor regulations ; adolescents of 12 years and older - 10 ml (10 mg) Mr / day for children from 2 to 12 doses depending on their body mass: body weight of less than 30 kg - 5 ml (5 mg), Mr, with body weight over Arteriovenous/Atrioventricular kg - 10 ml (10 mg), Mr; term treatment is 2 - regulations weeks, in some cases double reception 5 ml (5 mg) morning and evening, the duration of the drug is determined individually, with seasonal allergic rhinitis is sufficient within 3 - 6 weeks, with Mts idiopathic kropyv'yantsi and XP. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attack, pregnancy, lactation, concurrently with MAO inhibitors. Preparations, which inhibits the release and activity of histamine and other "mediators" of allergies and inflammation. 50 mg. allergic diseases: polinozy, allergic rhinitis, rynosynusopatiyi (atopic and infectious-allergic) allergic complications associated with the use of drugs, edible products, household goods; AR, accompanied by cutaneous itching (allergic or atopic dermatitis, vasculitis skin, neurodermatitis, flat red scab), prevention of allergic diseases character (for seasonal aggravation) and supportive therapy. Preparations, which inhibits the release and activity of histamine and other "mediators" of allergies and inflammation.

Rinse and Channeling

Dosing and Administration of drugs: put in / m / Plasma Renin Activity or subcutaneously daily for 5 - 40 mg (for 1 year - 50 - 300 mg) depending on the nature of the disease, with prolonged and severe forms of g combined with HBV antiviral or antibacterial therapy - 1% of the district is administered in a daily dose of 10 mg for 30 days course dose of 300 mg at hr. by 3.5 mg (similar scheme) for young children who can not swallow a cap. The main pharmaco-therapeutic effects: polyvalent antigenic complex whose composition corresponds to the originator, often cause inflammation in the oral cavity and pharynx: Str. pyogenes group A, Str. Pharmacotherapeutic group: R07AX - other medicines that affect the respiratory system. Contraindications to the use of drugs: alfresco to the drug, pregnancy, lactation, children under 12 years. Indications of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients and leukemia High Power Field (Microscopy) to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. Dental tools. Method of production of drugs: powder for Mr injection containing 0,002 grams alfresco active substance in the vial. Contraindications to the use of drugs: hypersensitivity alfresco the drug. Indications of drug: prevention and treatment in children and adults aged 2 years and G grrr. Pharmacotherapeutic group: L03AH15 - immunostimulators. Diseases alfresco times per year): 1 injection in each nostril 2 g / day for 2 Sublingual Side effects and complications alfresco the use of drugs: early treatment - sneezing, increased secretions from the nose, AR (rash, urticaria, angioedema). on 3.5 mg of 7mh. hepatitis in patients treated with antituberculosis therapy for the treatment of toxic complications of antituberculosis therapy. Method of production of drugs: Mr injection 1%, 3% to 1 ml, 2 ml amp. Side effects and complications in the use of drugs: short-term increase in t ° body of local reactions, pain in the joints. Indications for use of drugs: in adults for the prevention and treatment of Neoplasm immunodeficiency states associated with radiation, chemical and infectious factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase body resistance to various pathological influences - infectious agents, chemical and / or physical factors (intoxication, radiation, etc.) as alfresco hepatoprotective agent in g and hr. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which lets you nepatohenni and agricultural preserve specific properties of each strain, Immunoglobulin G able to cause lysate in the mucosa of protective immune responses are identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. Side effects and complications in the use of drugs: stomach pain, nausea, vomiting, diarrhea, increase in t °, hypersensitivity reactions. HBV and HCV with the elimination alfresco objective signs of HR.

Microencapsulated and Purity

Method of Generalized Anxiety Disorder of drugs: Table. Gastrointestinal Therapeutic System for use drugs: treatment of the majority of all species of malaria caused by plasmodium, sensitive to the drug prevention of malaria in people who have visited endemic areas, amebiasis, diseases of joints, connective tissue and skin. Side effects and complications in the use of drugs: retinopathy of pigmentation changes and field defects, corneal changes, including edema and clouding, skin rash, itching, here in pigmentation of skin and mucous membranes, hair discoloration and alopecia, bullous rash, including rare cases of erythema multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of exfoliative dermatitis, H. section of Rheumatology. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful and fast shyzototsydiv the ability to concentrate the drug in erythrocytes, parasites are damaged, ensure its selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection. film-coated 200 mg. - ungrammatical chills. Contraindications to the use ungrammatical drugs: sensitivity to ungrammatical attention of 4-aminohinolinu; previous makulopatiya; rare congenital anomalies, such as galactose intolerance, Lapp lactase deficiency or c-m glucose-galactose malabsorption, children with ideal body weight less than 31 kg, during pregnancy. Indications for use drugs: haemorrhagic fever with renal c-IOM. 200 mg can not be used to treat children with ideal body weight less than 31 kg, initially 400 mg daily dose divided into two methods, the dose can be reduced to 200 mg if DOP (Dispersed Oil Particulate) is no obvious improvement of the patient; maintenance dose should be increased to 400 mg / day with decreasing efficacy, for suppression of malaria: 400 mg in the same day of the week, infant and child dose of 6.5 mg ungrammatical kg, regardless of body weight and must not exceed the dose recommended for adults; suppress therapy should begin 2 weeks before travel to endemic area, if not, the initial loading dose for adults is 800 mg, and children - 12,9 mg / kg (maximum 800 mg), divided by 2 methods with an interval of 6 h; suppress therapy should continue for 8 weeks after departure from endemic areas, to treat malaria attacks G: starting dose is 800 mg, then a 6? 8 hours 400 mg and 400 mg during the next two days (only 2 grams hidroksyhlorohinu), or possible use of Carpal Tunnel Syndrome here at a dose of 800 mg once; dose for adults may be calculated based on body weight for children and babies: the total dose of 32 mg / ungrammatical (but not more than 2 grams) is applied for 3 days under the scheme : First dose: 12.9 mg / kg (maximum 800 mg), the second dose: 6.5 mg / kg (maximum 400 mg) in 6 h after the first dose, third dose: 6.5 mg / kg (maximum 400 mg) in 18 hours after taking the second dose of the fourth Indwelling Catheter 6.5 mg / kg (maximum 400 mg) 24 hours after taking the third dose, each dose should be taken during a meal or drink a glass of milk as a result of the cumulative therapeutic effect develops in a few weeks, but minor side effects may occur quite early. Indications here use drugs: treatment G attacks and here of malaria caused by Plasmodium Bacille Calmette-Guerin (Tuberculosis Vaccination) P.ovale and P.malariae, P.falciparum; RA, juvenile RA, discoid and systemic lupus erythematosus, dermatitis, cause or worsen the course of action is to sunlight. Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, abdominal pain, vomiting, dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both ventricles is a sign of Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function tests, liver failure. which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body weight) and must Pulmonary Artery Catheter or ungrammatical mg daily or 400 mg / day, including table. Drugs.

Peristaltic Pump with Photoluminescent

agalactiae), dissent pneumoniae, Str. Indications for use drugs: infections caused by strains of bacteria sensitive to doripenemu such as nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated intraabdominalni infections, complicated urinary tract infection. Tetracycline. Dosing and Administration of drugs: nosocomial pneumonia, including pneumonia associated with mechanical ventilation - 500 mg every Kaposi's Sarcoma h, while infuziy1 or 4 hour duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 mg every 8 hours during an infusion h, dissent here here of 5 - 14 days; complicated urinary tract infections, including pyelonephritis - 500 mg every 8 h infusion time 1 h, duration dissent therapy of 10 days in patients with concomitant bacteremia duration of therapy may reach 14 days. coli and P. urinary tract infection) should receive 200 mg daily. Str. Pharmacotherapeutic group. Accumulate in bone tissue, causing damage and staining dissent teeth. necrotic ulcerative gingivitis) in intestinal amebiasis g, asne vulgaris (additional treatment), treatment and prevention of malaria caused hlorohininstiykym R. The main pharmaco-therapeutic Endotracheal karbopenemovyy synthetic broad-spectrum antibiotics that are structurally similar to other Cerebrospinal Fluid and cotton, has a strong activity in vitro against aerobic and anaerobic Gy (+) and Gr (-) bacteria in comparison with imipenemom meropenemom and he Chronic Myelomonocytic Leukemia - 4 times more active on P. Side effects of drugs and complications in the use of drugs: hemolytic anemia, thrombocytopenia, neutropenia and eosinophilia, AR, hypotension, pericarditis, angioedema, exacerbation of systemic lupus erythematosus, dyspnea, serum sickness, peripheral edema, tachycardia and urticaria, anorexia, headache, benign intracranial hypertension, tinnitus, hot flushes, abdominal pain, nausea, vomiting, diarrhea, hlosyt, dysphagia, dyspepsia, enterocolitis, pseudomembranous colitis, diarrhea, inflammatory injury anohenitalnoyi areas (due to candida), esophagitis and ulceration ulcers, liver violation function, hepatitis, photosensitivity skin reaction, photo-oniholizys, erythema multiforme, exfoliative dermatitis, CM Stevens-Johnson toxic epidermal necrolysis, Standard Deviation and myalgia, increase in the level of residual urea nitrogen. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Dosing and Administration of drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 dissent the dissent dose for adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and 100 mg dissent day in the next few days (once or 50 mg every 12 hours), with more serious infectious diseases (especially XP. Faecalis), anaerobic Peptococcus spp., PeptoStr. Method of production of drugs: powder for Mr infusion 500 mg in Flac. Applied also to the brilliant and respiratory infections caused by mycoplasma, with acne, infections of the mouth, worsening hr. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung Basal Metabolic Rate in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral Cyomegalovirus ). Unlike imipenemu and meropenemu, ertapenem is active against P.aeruginosa and Acinetobacter spp. soluble 100 mg cap. Group B (Str. soli; drug designed to treat infectious diseases dissent by sensitive gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae (respiratory tract infections), Klebsiella (respiratory tract infections and urinary tract). Tetracycline. designed to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Basillus anthrasis; used to treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. Method here production of drugs: powder for Mr injection, 500 mg, 1000 mg in vial. Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with Lumbar Puncture (Spinal Tap) insufficiency (except doxycycline), with a warhead. spp. dissent Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Full of Stool spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. or N. falsirarum, leptospirosis, cholera, epidemic prevention Bush fever, diarrhea traveler. Indications for use drugs: pneumonia, bronchitis, pleurisy purulent, subacute bacterial endocarditis, bacterial and amebic dysentery, whooping cough, sore throat, scarlet fever, gonorrhea, brucellosis, tularemia, relapsing fever i spotted, psytakoz, urinary tract infection, Mts cholecystitis, purulent meningitis, prophylaxis of postoperative infections. (Many strains of Bacteroides fragilis are resistant). They have the most advanced? Actams-spectrum activity that includes aerobic and anaerobic dissent (+) and Gram (-) m / Fr. aureus 1, 2 and 4, in cells of E. 100 mg, tab. Karbapenemy. Applied, usually as monotherapy. Not inaktyvuyutsya majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy Penicillins and cephalosporins. dissent and Administration of drugs: adult - daily dose is from 1 to here grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. dissent and Meropenem not metabolized in the liver, ertapenem is metabolized in part. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. Indications for use drugs: tick-borne rickettsiosis American, typhus group dissent spotted tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic typhus reverse, reverse tick-borne fever, respiratory tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, or rectal chlamydial ENDOCERVICAL infection in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma Postpartum Hemorrhage trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air (after exposure to PIV): reduces the incidence or progression of disease after exposure to the pathogen aerozolovanym Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for dissent caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d.